LABORATORY RESEARCH GD3 Synthase Regulates Epithelial-Mesenchymal Transition and Metastasis in Breast Cancer Scientists demonstrate that the inhibition of GD3 synthase using small hairpin RNA or triptolide compromises the initiation and maintenance of epithelial-mesenchymal transition instigated by various signaling pathways, including Snail, Twist and transforming growth factor-β1 as well as the mesenchymal characteristics of claudin-low breast cancer cell lines. [Oncogene] Abstract Estrogen Receptor-Alpha 36 Mediates the Anti-Apoptotic Effect of Estradiol in Triple Negative Breast Cancer Cells via a Membrane-Associated Mechanism 17β-Estradiol can promote the growth and development of several estrogen receptor (ER)-negative breast cancers. Researchers determined if ERα36 mediates this anti-apoptotic effect, and elucidated the mechanism involved. [Biochim Biophys Acta] Abstract Enriched CD44+/CD24– Population Drives the Aggressive Phenotypes Presented in Triple-Negative Breast Cancer (TNBC) Investigators found the CD44+/CD24– cell population was enriched in TNBC tissues and cell lines, with a higher capacity of proliferation, migration, invasion and tumorigenicity as well as lower adhesion ability. [Cancer Lett] Abstract Poly (ADP-Ribose) Polymerase Inhibition Enhances Trastuzumab Antitumor Activity in HER2 Overexpressing Breast Cancer Investigators tested poly (ADP-ribose) polymerase (PARP) inhibition, alone or combined with the anti-HER2 antibody trastuzumab on HER2+ breast cancer. They used two PARP inhibitors in clinical development, olaparib and rucaparib, as well as genetic downmodulation of PARP-1 for in vitro studies. [Eur J Cancer] Abstract Vaccination with ErbB-2 Peptides Prevents Cancer Stem Cell Expansion and Suppresses the Development of Spontaneous Tumors in MMTV-PyMT Transgenic Mice Researchers investigated a peptide-based vaccine, which consists of two MHC class II epitopes derived from murine ErbB-2, to prevent the occurrence of spontaneous tumors in breast and assess immune impact on breast cancer stem cells. [Breast Cancer Res Treat] Abstract Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2 MAPK (ERK1/2) signaling regulates cellular processes including cell motility, adhesion, and invasion. Scientists investigated the regulation of ERK1/2 by Snail in breast cancer cells. [PLoS One] Full Article ARID3B Expression in Primary Breast Cancers and Breast Cancer-Derived Cell Lines AT-rich interaction domain 3 (ARID3B) has been linked to cellular immortalization, epithelial-mesenchymal transition and tumorigenesis. Given the emerging role of ARID3B in tumor development, researchers examined its expression in primary patient-derived breast cancer samples and breast cancer-derived cell lines. [Cell Oncol] Abstract CLINICAL RESEARCH Lapatinib with Trastuzumab for HER2-Positive Early Breast Cancer (NeoALTTO): Survival Outcomes of a Randomized, Open-Label, Multicenter, Phase III Trial and Their Association with Pathological Complete Response Findings from the randomized Phase III NeoALTTO trial in women with HER2-positive early breast cancer showed that the combination of lapatinib and trastuzumab significantly improved rates of pathological complete response compared with either drug alone. Researchers report data for the prespecified secondary endpoints of event-free and overall survival, and assess the association between these outcomes and pathological complete response. [Lancet Oncol] Abstract Phase II Gemcitabine and Capecitabine Combination Therapy in Recurrent or Metastatic Breast Cancer Patients Pretreated with Anthracycline and Taxane Investigators conducted a Phase II study evaluating safety and efficacy of combination gemcitabine and capecitabine therapy for metastatic breast cancer patients following anthracycline and taxane treatment in Korea. [Cancer Chemother Pharmacol] Abstract |